US Stock MarketDetailed Quotes

ANIX Anixa Biosciences

Watchlist

3.360
+0.060+1.82%

Trading Sep 17 10:01 ET

108.12MMarket Cap-8615P/E (TTM)

Anixa Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jul 31, 2024

(Q2)Apr 30, 2024

(Q1)Jan 31, 2024

(FY)Oct 31, 2023

(Q4)Oct 31, 2023

(Q3)Jul 31, 2023

(Q2)Apr 30, 2023

(Q1)Jan 31, 2023

(FY)Oct 31, 2022

(Q4)Oct 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-82.91%-2.64M

-80.42%-1.46M

-16.15%-2.31M

4.36%-6.21M

-23.60%-1.97M

-3.51%-1.45M

65.00%-807K

-66.08%-1.99M

-31.47%-6.49M

-52.44%-1.59M

Net income from continuing operations

-30.10%-3.32M

-37.84%-3.18M

-39.76%-3.29M

27.89%-9.93M

22.90%-2.72M

8.18%-2.55M

35.70%-2.31M

39.31%-2.35M

-4.90%-13.77M

13.31%-3.53M

Depreciation and amortization

-72.73%3K

0.00%12K

18.18%13K

9.52%46K

9.09%12K

10.00%11K

9.09%12K

10.00%11K

-30.00%42K

-31.25%11K

Other non cash items

184.38%182K

-69.44%22K

43.40%152K

-58.38%313K

-47.01%71K

-45.30%64K

-74.47%72K

-51.60%106K

35.50%752K

0.00%134K

Change In working capital

-385.60%-607K

73.18%452K

58.76%-292K

-318.56%-1.06M

-167.87%-488K

-60.26%-125K

155.06%261K

-322.64%-708K

521.79%485K

303.93%719K

-Change in receivables

-143.04%-192K

258.72%173K

-21.00%-121K

-672.41%-224K

320.69%64K

---79K

---109K

---100K

---29K

-Change in prepaid assets

-115.95%-758K

259.21%273K

0.95%212K

-272.60%-775K

-469.79%-710K

-2.03%-351K

-42.42%76K

211.70%210K

-677.78%-208K

23.87%192K

-Change in payables and accrued expense

11.99%355K

-93.75%19K

54.09%-370K

-101.97%-15K

-69.96%170K

15.27%317K

151.01%304K

-256.50%-806K

683.51%760K

1,615.15%566K

-Change in other current liabilities

833.33%88K

-30.00%-13K

-8.33%-13K

-21.05%-46K

-20.00%-12K

-33.33%-12K

0.00%-10K

-33.33%-12K

30.91%-38K

0.00%-10K

Cash from discontinued investing activities

Operating cash flow

-82.91%-2.64M

-80.42%-1.46M

-16.15%-2.31M

4.36%-6.21M

-23.60%-1.97M

-3.51%-1.45M

65.00%-807K

-66.08%-1.99M

-31.47%-6.49M

-52.44%-1.59M

Investing cash flow

Cash flow from continuing investing activities

377.96%2.72M

116.14%556K

122.05%129K

47.78%-5.6M

94.02%-593K

66.33%-980K

-1,477.60%-3.44M

-131.62%-585K

-173.88%-10.73M

-453.30%-9.92M

Net investment purchase and sale

377.96%2.72M

116.14%556K

122.05%129K

47.78%-5.6M

94.02%-593K

66.33%-980K

-1,477.60%-3.44M

-131.62%-585K

-170.98%-10.73M

-454.18%-9.92M

Cash from discontinued investing activities

Investing cash flow

377.96%2.72M

116.14%556K

122.05%129K

47.78%-5.6M

94.02%-593K

66.33%-980K

-1,477.60%-3.44M

-131.62%-585K

-173.88%-10.73M

-453.30%-9.92M

Financing cash flow

Cash flow from continuing financing activities

4,866.67%149K

1,007.41%897K

75,333.33%2.26M

-19.03%366K

172.66%279K

-99.64%3K

1,057.14%81K

-98.57%452K

-366.67%-384K

Net common stock issuance

---45K

--833K

--2.2M

----

--0

----

Proceeds from stock option exercised by employees

6,366.67%194K

-20.99%64K

2,133.33%67K

-19.03%366K

172.66%279K

-99.64%3K

1,057.14%81K

--3K

2.73%452K

-366.67%-384K

Cash from discontinued financing activities

Financing cash flow

4,866.67%149K

1,007.41%897K

75,333.33%2.26M

-19.03%366K

172.66%279K

-99.64%3K

1,057.14%81K

--3K

-98.57%452K

-366.67%-384K

Net cash flow

Beginning cash position

-82.30%995K

-89.81%998K

-92.60%915K

-57.57%12.36M

-86.81%3.2M

-79.73%5.62M

-67.13%9.79M

-57.57%12.36M

353.92%29.13M

-10.90%24.25M

Current changes in cash

109.50%230K

99.93%-3K

103.23%83K

31.74%-11.45M

80.81%-2.28M

30.36%-2.42M

-103.51%-4.17M

-493.57%-2.57M

-173.83%-16.77M

-724.03%-11.89M

End cash Position

-61.69%1.23M

-82.30%995K

-89.81%998K

-92.60%915K

-86.81%3.2M

-79.73%5.62M

-67.13%9.79M

-57.57%12.36M

Free cash flow

-82.91%-2.64M

-80.42%-1.46M

-16.15%-2.31M

4.36%-6.21M

-23.60%-1.97M

-3.51%-1.45M

65.00%-807K

-66.08%-1.99M

-31.47%-6.49M

-52.44%-1.59M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Jul 31, 2024	(Q2)Apr 30, 2024	(Q1)Jan 31, 2024	(FY)Oct 31, 2023	(Q4)Oct 31, 2023	(Q3)Jul 31, 2023	(Q2)Apr 30, 2023	(Q1)Jan 31, 2023	(FY)Oct 31, 2022	(Q4)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-82.91%-2.64M	-80.42%-1.46M	-16.15%-2.31M	4.36%-6.21M	-23.60%-1.97M	-3.51%-1.45M	65.00%-807K	-66.08%-1.99M	-31.47%-6.49M	-52.44%-1.59M
Net income from continuing operations	-30.10%-3.32M	-37.84%-3.18M	-39.76%-3.29M	27.89%-9.93M	22.90%-2.72M	8.18%-2.55M	35.70%-2.31M	39.31%-2.35M	-4.90%-13.77M	13.31%-3.53M
Depreciation and amortization	-72.73%3K	0.00%12K	18.18%13K	9.52%46K	9.09%12K	10.00%11K	9.09%12K	10.00%11K	-30.00%42K	-31.25%11K
Other non cash items	184.38%182K	-69.44%22K	43.40%152K	-58.38%313K	-47.01%71K	-45.30%64K	-74.47%72K	-51.60%106K	35.50%752K	0.00%134K
Change In working capital	-385.60%-607K	73.18%452K	58.76%-292K	-318.56%-1.06M	-167.87%-488K	-60.26%-125K	155.06%261K	-322.64%-708K	521.79%485K	303.93%719K
-Change in receivables	-143.04%-192K	258.72%173K	-21.00%-121K	-672.41%-224K	320.69%64K	---79K	---109K	---100K	---29K	---29K
-Change in prepaid assets	-115.95%-758K	259.21%273K	0.95%212K	-272.60%-775K	-469.79%-710K	-2.03%-351K	-42.42%76K	211.70%210K	-677.78%-208K	23.87%192K
-Change in payables and accrued expense	11.99%355K	-93.75%19K	54.09%-370K	-101.97%-15K	-69.96%170K	15.27%317K	151.01%304K	-256.50%-806K	683.51%760K	1,615.15%566K
-Change in other current liabilities	833.33%88K	-30.00%-13K	-8.33%-13K	-21.05%-46K	-20.00%-12K	-33.33%-12K	0.00%-10K	-33.33%-12K	30.91%-38K	0.00%-10K
Cash from discontinued investing activities
Operating cash flow	-82.91%-2.64M	-80.42%-1.46M	-16.15%-2.31M	4.36%-6.21M	-23.60%-1.97M	-3.51%-1.45M	65.00%-807K	-66.08%-1.99M	-31.47%-6.49M	-52.44%-1.59M
Investing cash flow
Cash flow from continuing investing activities	377.96%2.72M	116.14%556K	122.05%129K	47.78%-5.6M	94.02%-593K	66.33%-980K	-1,477.60%-3.44M	-131.62%-585K	-173.88%-10.73M	-453.30%-9.92M
Net investment purchase and sale	377.96%2.72M	116.14%556K	122.05%129K	47.78%-5.6M	94.02%-593K	66.33%-980K	-1,477.60%-3.44M	-131.62%-585K	-170.98%-10.73M	-454.18%-9.92M
Cash from discontinued investing activities
Investing cash flow	377.96%2.72M	116.14%556K	122.05%129K	47.78%-5.6M	94.02%-593K	66.33%-980K	-1,477.60%-3.44M	-131.62%-585K	-173.88%-10.73M	-453.30%-9.92M
Financing cash flow
Cash flow from continuing financing activities	4,866.67%149K	1,007.41%897K	75,333.33%2.26M	-19.03%366K	172.66%279K	-99.64%3K	1,057.14%81K	3K	-98.57%452K	-366.67%-384K
Net common stock issuance	---45K	--833K	--2.2M	----	----	--0	--0	--0	----	----
Proceeds from stock option exercised by employees	6,366.67%194K	-20.99%64K	2,133.33%67K	-19.03%366K	172.66%279K	-99.64%3K	1,057.14%81K	--3K	2.73%452K	-366.67%-384K
Cash from discontinued financing activities
Financing cash flow	4,866.67%149K	1,007.41%897K	75,333.33%2.26M	-19.03%366K	172.66%279K	-99.64%3K	1,057.14%81K	--3K	-98.57%452K	-366.67%-384K
Net cash flow
Beginning cash position	-82.30%995K	-89.81%998K	-92.60%915K	-57.57%12.36M	-86.81%3.2M	-79.73%5.62M	-67.13%9.79M	-57.57%12.36M	353.92%29.13M	-10.90%24.25M
Current changes in cash	109.50%230K	99.93%-3K	103.23%83K	31.74%-11.45M	80.81%-2.28M	30.36%-2.42M	-103.51%-4.17M	-493.57%-2.57M	-173.83%-16.77M	-724.03%-11.89M
End cash Position	-61.69%1.23M	-82.30%995K	-89.81%998K	-92.60%915K	-92.60%915K	-86.81%3.2M	-79.73%5.62M	-67.13%9.79M	-57.57%12.36M	-57.57%12.36M
Free cash flow	-82.91%-2.64M	-80.42%-1.46M	-16.15%-2.31M	4.36%-6.21M	-23.60%-1.97M	-3.51%-1.45M	65.00%-807K	-66.08%-1.99M	-31.47%-6.49M	-52.44%-1.59M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data